Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Author(s) -
Nasser H. Hanna,
David H. Johnson,
Sarah Temin,
Gregory A. Masters
Publication year - 2017
Publication title -
journal of oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.555
H-Index - 60
eISSN - 1935-469X
pISSN - 1554-7477
DOI - 10.1200/jop.2017.026716
Subject(s) - medicine , pemetrexed , erlotinib , oncology , gefitinib , crizotinib , docetaxel , lung cancer , carboplatin , afatinib , guideline , bevacizumab , chemotherapy , cancer , epidermal growth factor receptor , pathology , malignant pleural effusion , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom